Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Co-artemether for Acute Uncomplicated Malaria in Non-immune Patients
NCT00233337Phase 4Completed
- Sponsor
- Novartis
- Start
- May 2001
- Primary completion
- Aug 2005
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of artemether + lumefantrine in Plasmodium falciparum malaria, sponsored by Novartis. Started May 2001; status: completed.
02
Drugs
artemether + lumefantrine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT00233337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00233337.